CXCL1 and acute kidney injury: Our data shows the critical role which the chemokine CXCL1 plays in cisplatin-induced kidney inflammation, while also providing an opportunity for the evaluation of therapeutic interventions based on this, and other inflammatory biomarkers, in AKI.